84,254 Shares in CME Group Inc. $CME Acquired by Engineers Gate Manager LP

Engineers Gate Manager LP bought a new position in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 84,254 shares of the financial services provider’s stock, valued at approximately $18,606,000.

A number of other hedge funds have also bought and sold shares of CME. Whipplewood Advisors LLC raised its holdings in shares of CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after buying an additional 83 shares during the last quarter. Elkhorn Partners Limited Partnership purchased a new stake in shares of CME Group during the fourth quarter valued at $27,000. Hilton Head Capital Partners LLC acquired a new position in shares of CME Group in the 4th quarter valued at $28,000. Mowery & Schoenfeld Wealth Management LLC acquired a new position in shares of CME Group in the 2nd quarter valued at $28,000. Finally, Bayban purchased a new position in CME Group in the 4th quarter worth $31,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the subject of a number of research reports. Wall Street Zen raised CME Group from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 29th. Morgan Stanley increased their price objective on CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a report on Thursday, July 23rd. JPMorgan Chase & Co. raised their price objective on CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a research note on Thursday, July 23rd. TD Cowen reaffirmed a “buy” rating and set a $292.00 target price on shares of CME Group in a report on Thursday, September 3rd. Finally, Weiss Ratings downgraded shares of CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, CME Group presently has a consensus rating of “Hold” and a consensus target price of $289.75.

Insiders Place Their Bets

In related news, Director William Shepard purchased 325 shares of CME Group stock in a transaction that occurred on Thursday, June 25th. The stock was bought at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the transaction, the director owned 260,442 shares in the company, valued at $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.30% of the company’s stock.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Shareholder distribution: CME is scheduled to distribute approximately $467 million in dividends on September 25, reinforcing its appeal to income-oriented investors and highlighting the exchange operator’s strong cash-generation profile. CME Group’s $467 Million Dividend: What Shareholders Collect Sept. 25
• Positive Sentiment: Product expansion: CME’s new single-stock futures offer investors leveraged and capital-efficient exposure to individual equities. The product broadens CME’s equity derivatives lineup and could create additional trading volume and fee revenue over time. CME’s New Single Stock Futures: What Are The Advantages Vs. Stocks?
• Positive Sentiment: European market entry: CME plans to enter the European dairy market through a deal involving EEX, expanding its addressable market and potentially improving its international commodities presence. CME Group to enter European dairy market through EEX deal
• Neutral Sentiment: Leadership succession: CME named insider Jack Tobin as CFO, succeeding Lynne Fitzpatrick, who is expected to become CEO in March 2027. The planned internal transition may provide continuity, although investors could monitor execution during the leadership change. CME Group names Jack Tobin as CFO
• Neutral Sentiment: Interest-rate backdrop: Reports that Federal Reserve Chair Warsh favors rate hikes, while the Treasury considers buying longer-maturity debt, point to continued uncertainty over rates, inflation and bond-market conditions. These factors can affect CME’s interest-rate and fixed-income trading volumes. Fed and Treasury at Odds
• Negative Sentiment: Regulatory litigation: The Hyperliquid Policy Center filed an amicus brief urging dismissal of CME’s lawsuit against the CFTC. The development adds uncertainty to CME’s regulatory position and could weigh on sentiment surrounding its digital-asset and derivatives initiatives. Hyperliquid Policy Center Files Amicus Brief Urging Dismissal of CME’s Suit Against CFTC

CME Group Price Performance

NASDAQ:CME opened at $274.70 on Thursday. The firm’s fifty day moving average is $262.03 and its two-hundred day moving average is $277.67. The firm has a market cap of $98.78 billion, a price-to-earnings ratio of 23.30, a PEG ratio of 3.29 and a beta of 0.24. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company’s revenue was up .8% on a year-over-year basis. During the same quarter last year, the business posted $2.96 EPS. Research analysts expect that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is 44.11%.

CME Group Company Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for a broad range of financial and commodity products. Its exchange platforms enable participants to manage risk, discover prices and gain exposure to asset classes including interest rates, equity indexes, foreign exchange, energy, metals, agricultural commodities and digital assets.

The company’s principal marketplaces include CME, CBOT, NYMEX and COMEX. Products are offered through futures and options contracts, with electronic trading available through CME Globex as well as exchange-based and privately negotiated transactions.